BRCA1 and cancer: Thus, determining whether BRCA1 heterozygosity confers haploinsufficiency on HMECs for any of the multiple, known, BRCA1 functions is a potentially valuable step in achieving a better understanding of BRCA1 mutation-driven cancer predisposition.